Brent L Wood Selected Research

Indicators and Reagents (Reagents)

1/2020	Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
1/2018	Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
1/2013	Flow cytometric monitoring of residual disease in acute leukemia.
1/2007	2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brent L Wood Research Topics

Disease

37	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 05/2010
29	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 08/2009
18	Residual Neoplasm 01/2020 - 05/2010
15	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023 - 05/2010
15	Neoplasms (Cancer) 01/2022 - 05/2002
12	Leukemia 10/2022 - 02/2008
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 03/2011
5	Philadelphia Chromosome 10/2022 - 01/2017
4	Lymphoma (Lymphomas) 01/2022 - 05/2002
4	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2007
3	Multiple Myeloma 11/2019 - 02/2014
3	Hodgkin Disease (Hodgkin's Disease) 02/2017 - 11/2010
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 05/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 09/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 09/2008
1	Glucocorticoid Receptor Deficiency 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018
1	Aneuploidy (Aneuploid) 02/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 11/2016
1	Macrocytic Anemia 11/2016
1	Osteonecrosis (Kienbock's Disease) 10/2016
1	Juvenile Myelomonocytic Leukemia 01/2016
1	Splenomegaly 01/2016

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 11/2023 - 09/2003
6	pegaspargase (Oncaspar)FDA Link 10/2021 - 07/2015
5	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 07/2015
5	Monoclonal AntibodiesIBA 01/2018 - 05/2002
4	blinatumomabIBA 11/2023 - 01/2017
4	nelarabine (506U78)FDA Link 11/2022 - 07/2015
4	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016 - 01/2013
2	Bortezomib (Velcade)FDA Link 03/2024 - 01/2022
2	Dasatinib (BMS 354825)FDA Link 11/2023 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 05/2002
2	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 05/2002
2	CytokinesIBA 01/2022 - 01/2020
2	GlucocorticoidsIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2018
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 10/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 04/2016
2	Chimeric Antigen ReceptorsIBA 11/2019 - 09/2008
2	LigandsIBA 11/2019 - 02/2017
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 08/2017
2	treosulfanIBA 01/2018 - 03/2011
2	fludarabineIBA 01/2018 - 03/2011
2	Clofarabine (Clolar)FDA Link 08/2015 - 04/2015
2	StreptavidinIBA 02/2014 - 02/2008
2	procaine isothiocyanate (PRIT)IBA 02/2014 - 02/2008
2	lintuzumabIBA 01/2013 - 08/2009
2	ParaffinIBA 07/2012 - 05/2003
1	Prednisone (Sone)FDA LinkGeneric 11/2023
1	Inotuzumab OzogamicinIBA 01/2023
1	NucleosidesIBA 11/2022
1	Plant NectarIBA 11/2022
1	SEC Translocation ChannelsIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	SteroidsIBA 01/2020
1	B-Cell Maturation AntigenIBA 11/2019
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2019
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2019
1	Polycomb Repressive Complex 2IBA 12/2018
1	methylervineIBA 10/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	daratumumabIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Immunoglobulin D (IgD)IBA 02/2017
1	B7-H1 AntigenIBA 02/2017
1	Immunoglobulin M (IgM)IBA 02/2017
1	FenretinideIBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	RetinoidsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	GlobinsIBA 11/2016
1	Heme (Haem)IBA 11/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2016
1	tosedostatIBA 01/2016
1	Decitabine FDA Link 01/2016
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2015

Therapy/Procedure

32	Therapeutics 03/2024 - 05/2002
17	Drug Therapy (Chemotherapy) 01/2024 - 05/2010
17	Cell Transplantation 01/2023 - 03/2011
4	Transplantation 02/2016 - 05/2002
3	Immunotherapy 11/2023 - 01/2018
3	Radioimmunotherapy 02/2014 - 05/2002
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2019
2	Cranial Irradiation 10/2018 - 01/2018
2	Aftercare (After-Treatment) 05/2012 - 04/2008
1	Radiotherapy 12/2021
1	Consolidation Chemotherapy 12/2017
1	Remission Induction 01/2017
1	Homologous Transplantation 01/2016